{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T01:33:04Z","timestamp":1778203984155,"version":"3.51.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T00:00:00Z","timestamp":1548288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T00:00:00Z","timestamp":1548288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Three-dimensional cell cultures, such as multicellular spheroids (MCS), reflect the <jats:italic>in vivo<\/jats:italic> architecture of solid tumours and multicellular drug resistance. We previously identified interferon regulatory factor 9 (IRF9) to be responsible for the up-regulation of a subset of interferon (IFN)-stimulated genes (ISGs) in MCS of colon carcinoma cells. This set of ISGs closely resembled a previously identified IFN-related DNA-damage resistance signature (IRDS) that was correlated to resistance to chemo- and radiotherapy. In this study we found that transcription factor STAT3 is activated upstream of IRF9 and binds to the IRF9 promoter in MCS of HCT116 colorectal carcinoma cells. Transferring conditioned media (CM) from high cell density conditions to non-confluent cells resulted in STAT3 activation and increased expression of IRF9 and a panel of IRDS genes, also observed in MCS, suggesting the involvement of a soluble factor. Furthermore, we identified gp130\/JAK signalling to be responsible for STAT3 activation, IRF9, and IRDS gene expression in MCS and by CM. Our data suggests a novel mechanism where STAT3 is activated in high cell density conditions resulting in increased expression of IRF9 and, in turn, IRDS genes, underlining a mechanism by which drug resistance is regulated.<\/jats:p>","DOI":"10.1038\/s41598-018-37294-z","type":"journal-article","created":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T11:05:12Z","timestamp":1548327912000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["STAT3 is activated in multicellular spheroids of colon carcinoma cells and mediates expression of IRF9 and interferon stimulated genes"],"prefix":"10.1038","volume":"9","author":[{"given":"Elin","family":"Edsb\u00e4cker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5778-7014","authenticated-orcid":false,"given":"Jason T.","family":"Serviss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iryna","family":"Kolosenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Palm-Apergi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"De Milito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6359-1256","authenticated-orcid":false,"given":"Katja Pokrovskaja","family":"Tamm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,24]]},"reference":[{"key":"37294_CR1","doi-asserted-by":"publisher","first-page":"R16","DOI":"10.1186\/bcr3100","volume":"14","author":"SR Chan","year":"2012","unstructured":"Chan, S. R. et al. STAT1-deficient mice spontaneously develop estrogen receptor \u03b1-positive luminal mammary carcinomas. Breast Cancer Res. BCR 14, R16 (2012).","journal-title":"Breast Cancer Res. BCR"},{"key":"37294_CR2","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1038\/nm.2830","volume":"18","author":"BN Bidwell","year":"2012","unstructured":"Bidwell, B. N. et al. Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape. Nat. Med. 18, 1224\u20131231 (2012).","journal-title":"Nat. Med."},{"key":"37294_CR3","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1089\/10799900252952244","volume":"22","author":"S Picaud","year":"2002","unstructured":"Picaud, S., Bardot, B., De Maeyer, E. & Seif, I. Enhanced tumor development in mice lacking a functional type I interferon receptor. J. Interferon Cytokine Res. Off. J. Int. Soc. Interferon Cytokine Res. 22, 457\u2013462 (2002).","journal-title":"J. Interferon Cytokine Res. Off. J. Int. Soc. Interferon Cytokine Res."},{"key":"37294_CR4","doi-asserted-by":"publisher","first-page":"18490","DOI":"10.1073\/pnas.0809242105","volume":"105","author":"RR Weichselbaum","year":"2008","unstructured":"Weichselbaum, R. R. et al. An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer. Proc. Natl. Acad. Sci. USA 105, 18490\u201318495 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"37294_CR5","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1073\/pnas.0308102100","volume":"101","author":"NN Khodarev","year":"2004","unstructured":"Khodarev, N. N. et al. STAT1 is overexpressed in tumors selected for radioresistance and confers protection from radiation in transduced sensitive cells. Proc. Natl. Acad. Sci. USA 101, 1714\u20131719 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"37294_CR6","doi-asserted-by":"publisher","first-page":"9214","DOI":"10.1158\/0008-5472.CAN-07-1019","volume":"67","author":"NN Khodarev","year":"2007","unstructured":"Khodarev, N. N. et al. Signal transducer and activator of transcription 1 regulates both cytotoxic and prosurvival functions in tumor cells. Cancer Res. 67, 9214\u20139220 (2007).","journal-title":"Cancer Res."},{"key":"37294_CR7","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.1158\/0008-5472.CAN-06-4250","volume":"67","author":"M-H Tsai","year":"2007","unstructured":"Tsai, M.-H. et al. Gene expression profiling of breast, prostate, and glioma cells following single versus fractionated doses of radiation. Cancer Res. 67, 3845\u20133852 (2007).","journal-title":"Cancer Res."},{"key":"37294_CR8","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1038\/sj.bjc.6602447","volume":"92","author":"D Roberts","year":"2005","unstructured":"Roberts, D. et al. Identification of genes associated with platinum drug sensitivity and resistance in human ovarian cancer cells. Br. J. Cancer 92, 1149\u20131158 (2005).","journal-title":"Br. J. Cancer"},{"key":"37294_CR9","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/ijc.22291","volume":"120","author":"M Frykn\u00e4s","year":"2007","unstructured":"Frykn\u00e4s, M. et al. STAT1 signaling is associated with acquired crossresistance to doxorubicin and radiation in myeloma cell lines. Int. J. Cancer 120, 189\u2013195 (2007).","journal-title":"Int. J. Cancer"},{"key":"37294_CR10","first-page":"6540","volume":"61","author":"KE Luker","year":"2001","unstructured":"Luker, K. E., Pica, C. M., Schreiber, R. D. & Piwnica-Worms, D. Overexpression of IRF9 confers resistance to antimicrotubule agents in breast cancer cells. Cancer Res. 61, 6540\u20136547 (2001).","journal-title":"Cancer Res."},{"key":"37294_CR11","doi-asserted-by":"publisher","first-page":"7227","DOI":"10.1073\/pnas.94.14.7227","volume":"94","author":"X Weihua","year":"1997","unstructured":"Weihua, X., Lindner, D. J. & Kalvakolanu, D. V. The interferon-inducible murinep48 (ISGF3\u03b3) gene is regulated by protooncogene\u2009c-myc. Proc. Natl. Acad. Sci. USA 94, 7227\u20137232 (1997).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"37294_CR12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/BF00689632","volume":"13","author":"PL Olive","year":"1994","unstructured":"Olive, P. L. & Durand, R. E. Drug and radiation resistance in spheroids: cell contact and kinetics. Cancer Metastasis Rev. 13, 121\u2013138 (1994).","journal-title":"Cancer Metastasis Rev."},{"key":"37294_CR13","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S1040-8428(00)00086-X","volume":"36","author":"B Desoize","year":"2000","unstructured":"Desoize, B. & Jardillier, J. Multicellular resistance: a paradigm for clinical resistance? Crit. Rev. Oncol. Hematol. 36, 193\u2013207 (2000).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"37294_CR14","doi-asserted-by":"publisher","first-page":"E51","DOI":"10.1002\/ijc.29161","volume":"136","author":"I Kolosenko","year":"2015","unstructured":"Kolosenko, I. et al. Cell crowding induces interferon regulatory factor 9, which confers resistance to chemotherapeutic drugs. Int. J. Cancer 136, E51\u201361 (2015).","journal-title":"Int. J. Cancer"},{"key":"37294_CR15","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1089\/jir.2009.0032","volume":"30","author":"MRS Rani","year":"2010","unstructured":"Rani, M. R. S. et al. STAT-phosphorylation-independent induction of interferon regulatory factor-9 by interferon-beta. J. Interferon Cytokine Res. Off. J. Int. Soc. Interferon Cytokine Res. 30, 163\u2013170 (2010).","journal-title":"J. Interferon Cytokine Res. Off. J. Int. Soc. Interferon Cytokine Res."},{"key":"37294_CR16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0167-4781(00)00111-1","volume":"1492","author":"X Weihua","year":"2000","unstructured":"Weihua, X., Hu, J., Roy, S. K., Mannino, S. B. & Kalvakolanu, D. V. Interleukin-6 modulates interferon-regulated gene expression by inducing the ISGF3 gamma gene using CCAAT\/enhancer binding protein-beta(C\/EBP-beta). Biochim. Biophys. Acta 1492, 163\u2013171 (2000).","journal-title":"Biochim. Biophys. Acta"},{"key":"37294_CR17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1073\/pnas.94.1.103","volume":"94","author":"X Weihua","year":"1997","unstructured":"Weihua, X., Kolla, V. & Kalvakolanu, D. V. Interferon \u03b3-induced transcription of the murine ISGF3\u03b3 (p48) gene is mediated by novel\u2009factors. Proc. Natl. Acad. Sci. USA 94, 103\u2013108 (1997).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"37294_CR18","doi-asserted-by":"publisher","first-page":"3608","DOI":"10.1038\/sj.onc.1206523","volume":"22","author":"RA Steinman","year":"2003","unstructured":"Steinman, R. A., Wentzel, A., Lu, Y., Stehle, C. & Grandis, J. R. Activation of Stat3 by cell confluence reveals negative regulation of Stat3 by cdk2. Oncogene 22, 3608\u20133615 (2003).","journal-title":"Oncogene"},{"key":"37294_CR19","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1158\/1541-7786.MCR-07-0317","volume":"5","author":"S Kreis","year":"2007","unstructured":"Kreis, S., Munz, G. A., Haan, S., Heinrich, P. C. & Behrmann, I. Cell density dependent increase of constitutive signal transducers and activators of transcription 3 activity in melanoma cells is mediated by Janus kinases. Mol. Cancer Res. MCR 5, 1331\u20131341 (2007).","journal-title":"Mol. Cancer Res. MCR"},{"key":"37294_CR20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1089\/jir.2010.0100","volume":"31","author":"H Cheon","year":"2011","unstructured":"Cheon, H., Yang, J. & Stark, G. R. The Functions of Signal Transducers and Activators of Transcriptions 1 and 3 as Cytokine-Inducible Proteins. J. Interferon Cytokine Res. 31, 33\u201340 (2011).","journal-title":"J. Interferon Cytokine Res."},{"key":"37294_CR21","first-page":"217","volume":"4","author":"C Becker","year":"2005","unstructured":"Becker, C. et al. IL-6 signaling promotes tumor growth in colorectal cancer. Cell Cycle Georget. Tex 4, 217\u2013220 (2005).","journal-title":"Cell Cycle Georget. Tex"},{"key":"37294_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V74.1.1.1","volume":"74","author":"T Kishimoto","year":"1989","unstructured":"Kishimoto, T. The biology of interleukin-6. Blood 74, 1\u201310 (1989).","journal-title":"Blood"},{"key":"37294_CR23","first-page":"a028415","volume":"10","author":"S Rose-John","year":"2018","unstructured":"Rose-John, S. Interleukin-6 FamilyCytokines. Cold Spring Harb. Perspect. Biol. 10, a028415 (2018).","journal-title":"Perspect. Biol."},{"key":"37294_CR24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nrc1275","volume":"4","author":"H Yu","year":"2004","unstructured":"Yu, H. & Jove, R. The STATs of cancer\u2013new molecular targets come of age. Nat. Rev. Cancer 4, 97\u2013105 (2004).","journal-title":"Nat. Rev. Cancer"},{"key":"37294_CR25","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1189\/jlb.0410217","volume":"88","author":"JS Silver","year":"2010","unstructured":"Silver, J. S. & Hunter, C. A. gp130 at the nexus of inflammation, autoimmunity, and cancer. J. Leukoc. Biol. 88, 1145\u20131156 (2010).","journal-title":"J. Leukoc. Biol."},{"key":"37294_CR26","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1158\/1535-7163.MCT-12-1082","volume":"12","author":"S Xu","year":"2013","unstructured":"Xu, S., Grande, F., Garofalo, A. & Neamati, N. Discovery of a Novel Orally Active Small-Molecule gp130 Inhibitor for the Treatment of Ovarian Cancer. Mol. Cancer Ther. 12, 937\u2013949 (2013).","journal-title":"Mol. Cancer Ther."},{"key":"37294_CR27","doi-asserted-by":"publisher","unstructured":"Xiang, M. et al. Gene expression-based discovery of atovaquone as a STAT3 inhibitor and anti-cancer agent. Blood, https:\/\/doi.org\/10.1182\/blood-2015-07-660506 (2016).","DOI":"10.1182\/blood-2015-07-660506"},{"key":"37294_CR28","doi-asserted-by":"publisher","first-page":"16975","DOI":"10.1073\/pnas.1315862110","volume":"110","author":"Y Wang","year":"2013","unstructured":"Wang, Y., van Boxel-Dezaire, A. H. H., Cheon, H., Yang, J. & Stark, G. R. STAT3 activation in response to IL-6 is prolonged by the binding of IL-6 receptor to EGF receptor. Proc. Natl. Acad. Sci. USA 110, 16975\u201316980 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"37294_CR29","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1053\/j.gastro.2017.06.008","volume":"153","author":"J Wang","year":"2017","unstructured":"Wang, J. et al. Colorectal Cancer Cell Line Proteomes Are Representative of Primary Tumors and Predict Drug Sensitivity. Gastroenterology 153, 1082\u20131095 (2017).","journal-title":"Gastroenterology"},{"key":"37294_CR30","doi-asserted-by":"publisher","first-page":"e0160125","DOI":"10.1371\/journal.pone.0160125","volume":"11","author":"K Ji","year":"2016","unstructured":"Ji, K. et al. The Role of p-STAT3 as a Prognostic and Clinicopathological Marker in Colorectal Cancer: A Systematic Review and Meta-Analysis. PloS One 11, e0160125 (2016).","journal-title":"PloS One"},{"key":"37294_CR31","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1038\/sj.onc.1207378","volume":"23","author":"A Vultur","year":"2004","unstructured":"Vultur, A. et al. Cell-to-cell adhesion modulates Stat3 activity in normal and breast carcinoma cells. Oncogene 23, 2600\u20132616 (2004).","journal-title":"Oncogene"},{"key":"37294_CR32","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.canlet.2005.10.047","volume":"242","author":"A Anagnostopoulou","year":"2006","unstructured":"Anagnostopoulou, A. et al. Differential effects of Stat3 inhibition in sparse vs confluent normal and breast cancer cells. Cancer Lett. 242, 120\u2013132 (2006).","journal-title":"Cancer Lett."},{"key":"37294_CR33","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1158\/0008-5472.CAN-14-2611","volume":"76","author":"MC Park","year":"2016","unstructured":"Park, M. C. et al. Novel Morphologic and Genetic Analysis of Cancer Cells in a 3D Microenvironment Identifies STAT3 as a Regulator of Tumor Permeability Barrier Function. Cancer Res. 76, 1044\u20131054 (2016).","journal-title":"Cancer Res."},{"key":"37294_CR34","first-page":"3513","volume":"46","author":"JP Freyer","year":"1986","unstructured":"Freyer, J. P. & Sutherland, R. M. Proliferative and clonogenic heterogeneity of cells from EMT6\/Ro multicellular spheroids induced by the glucose and oxygen supply. Cancer Res. 46, 3513\u20133520 (1986).","journal-title":"Cancer Res."},{"key":"37294_CR35","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S1040-8428(00)00077-9","volume":"36","author":"RC Bates","year":"2000","unstructured":"Bates, R. C., Edwards, N. S. & Yates, J. D. Spheroids and cell survival. Crit. Rev. Oncol. Hematol. 36, 61\u201374 (2000).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"37294_CR36","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/j.1747-0285.2011.01170.x","volume":"78","author":"W Fayad","year":"2011","unstructured":"Fayad, W. et al. Identification of agents that induce apoptosis of multicellular tumour spheroids: enrichment for mitotic inhibitors with hydrophobic properties. Chem. Biol. Drug Des. 78, 547\u2013557 (2011).","journal-title":"Chem. Biol. Drug Des."},{"key":"37294_CR37","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1080\/09553000701727531","volume":"83","author":"J Friedrich","year":"2007","unstructured":"Friedrich, J., Ebner, R. & Kunz-Schughart, L. A. Experimental anti-tumor therapy in 3-D: spheroids\u2013old hat or new challenge? Int. J. Radiat. Biol. 83, 849\u2013871 (2007).","journal-title":"Int. J. Radiat. Biol."},{"key":"37294_CR38","doi-asserted-by":"publisher","first-page":"E498","DOI":"10.1073\/pnas.1715118115","volume":"115","author":"L Lu","year":"2018","unstructured":"Lu, L. et al. Gene regulation and suppression of type I interferon signaling by STAT3 in diffuse large B cell lymphoma. Proc. Natl. Acad. Sci. USA 115, E498\u2013E505 (2018).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"37294_CR39","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.1128\/MCB.14.5.3186","volume":"14","author":"UM Wegenka","year":"1994","unstructured":"Wegenka, U. M. et al. The interleukin-6-activated acute-phase response factor is antigenically and functionally related to members of the signal transducer and activator of transcription (STAT) family. Mol. Cell. Biol. 14, 3186\u20133196 (1994).","journal-title":"Mol. Cell. Biol."},{"key":"37294_CR40","doi-asserted-by":"publisher","first-page":"6675","DOI":"10.1074\/jbc.M001748200","volume":"276","author":"GB Ehret","year":"2001","unstructured":"Ehret, G. B. et al. DNA binding specificity of different STAT proteins. Comparison of in vitro specificity with natural target sites. J. Biol. Chem. 276, 6675\u20136688 (2001).","journal-title":"J. Biol. Chem."},{"key":"37294_CR41","doi-asserted-by":"publisher","first-page":"21499","DOI":"10.1073\/pnas.1016147107","volume":"107","author":"J Yang","year":"2010","unstructured":"Yang, J. et al. Reversible methylation of promoter-bound STAT3 by histone-modifying enzymes. Proc. Natl. Acad. Sci. USA 107, 21499\u201321504 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"37294_CR42","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.pharmthera.2016.03.013","volume":"163","author":"S Nath","year":"2016","unstructured":"Nath, S. & Devi, G. R. Three-Dimensional Culture Systems in Cancer Research: Focus on Tumor Spheroid Model. Pharmacol. Ther. 163, 94\u2013108 (2016).","journal-title":"Pharmacol. Ther."},{"key":"37294_CR43","doi-asserted-by":"publisher","first-page":"24152","DOI":"10.1074\/jbc.M312219200","volume":"279","author":"L Thyrell","year":"2004","unstructured":"Thyrell, L. et al. Interferon alpha-induced apoptosis in tumor cells is mediated through the phosphoinositide 3-kinase\/mammalian target of rapamycin signaling pathway. J. Biol. Chem. 279, 24152\u201324162 (2004).","journal-title":"J. Biol. Chem."},{"key":"37294_CR44","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods San Diego Calif 25, 402\u2013408 (2001).","journal-title":"Methods San Diego Calif"},{"key":"37294_CR45","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing (2017)."},{"key":"37294_CR46","doi-asserted-by":"crossref","unstructured":"Wickham, H. ggplot2: Elegant Graphics for Data Analysis (Springer-Verlag 2016).","DOI":"10.1007\/978-3-319-24277-4"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37294-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37294-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37294-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T05:05:48Z","timestamp":1671253548000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37294-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,24]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["37294"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-37294-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,24]]},"assertion":[{"value":"25 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"536"}}